Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

NCT03195023 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency, Chronic
Proteinuria

Interventions

DRUG: Lisinopril
DRUG: Amlodipine

Sponsor

Hospital General Universitario Gregorio Marañon